Increasing prevalence of acne and other skin disorders across the globe and growing awareness toward personal hygiene are estimated to boost the growth of the global medicated wipes market at a CAGR of 6.17% during the forecast period 2022 to 2030

Increasing prevalence of acne and other skin disorders across the globe and growing awareness toward personal hygiene are estimated to boost the growth of the global medicated wipes market at a CAGR of 6.17% during the forecast period 2022 to 2030

Market Research Future (MRFR) has published a cooked research report on the “global medicated wipes market that contains the information from 2018 to 2030. The medicated wipes market is projected to register a CAGR of 6.17% during the forecast period of 2022 to 2030.


MRFR recognizes the following companies as the key players in the global medicated wipes market— Procter & Gamble (US), 3M (US), Johnson & Johnson (US), Clorox Company (US), Diamond Wipes International Inc. (US), Kimberly-Clark Corporation (US), Costco Wholesale Corporation (US), Pfizer Inc. (US), Reckitt Benckiser Group plc. (UK), Blistex Inc. (US), and others.


 


Market Highlights


The global medicated wipes market is accounted to register a CAGR of 6.17% during the forecast period and is projected to hit USD 10.95 billion by 2030.


Medicated wipes are being used to relieve discomfort or irritation. Medicated Wipes are used by adults as well as children. The growth of the global medicated wipes market is attributed to the increasing prevalence of acne and other skin disorders across the globe and growing awareness toward personal hygiene. Furthermore, the growing usage of biodegradable material for sustainable production of medicated wipes provide growth opportunities for the market in the future. However, the concerns pertaining to rashes and allergies might hinder the market's growth in the forecast period.


Segment Analysis


The global medicated wipes market has been segmented based on product, type of packaging, application, and distribution channel.


On the basis of indication, the market is bifurcated into dry and wet.


Based on type of packaging, the global medicated wipes market has been bifurcated into single pack and bundled pack.


On the basis of application, the market is segmented into hemorrhoid care, feminine care, acne treatment, skin disinfection & anti-allergy, and others.


Based on distribution channel, the global medicated wipes market has been segmented into pharmacies & drugstores, supermarkets & hypermarkets, e-commerce, and others.


Regional Analysis


The global medicated wipes market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe medicated wipes market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The medicated wipes market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World medicated wipes market comprises of Middle East, Africa, and Latin America.


The high proportion of the population suffering from acne, increasing concerns regarding aesthetic beauty, and the presence of a large number of market players in the North America are boosting market growth. For instance, in 2021, PDI (US) introduced its Sani-Cloth Bleach Clinical Size Wipe, of dimensions 6 x 5. The wipes aimed to minimize unnecessary waste for smaller medical equipment.


Moreover, the rising consumer knowledge regarding personal hygiene, and key players that are actively investing in research and development to introduce novel and premium products across the region are driving the growth in the European market.


Furthermore, owing to the rising geriatric population, increasing concerns regarding aesthetic beauty, and developing healthcare infrastructure are the major factors driving the market growth in the Asia-Pacific region. In addition, increasing funds from public and private organizations and individuals directly supports the growth of the Asia-Pacific medicated wipes market.


Additionally, rest of the world accounted for the lowest market share in the medicated wipes market. The growing prevalence of healthcare-associated infections (HAIs) in the public health sector. This is primarily attributable to the absence of a surveillance system. These HAIs are majorly responsible for mortality and morbidity in hospitalized patients. One in every seven patients hospitalized is at the risk of acquiring a healthcare-associated infection.


Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Medicated Wipes Market Research Report


Key Findings of the Study



  • The global medicated wipes market is expected to reach USD 10.95 billion by 2030 at a CAGR of 6.17% during the forecast period.

  • The Asia-Pacific region accounted for the fastest growing of the global market, due to increasing prevalence of acne and the increasing demand for medicated wipes for the treatment of acne and incontinence.

  • Based on application, the hemorrhoid care segment held the largest market in 2021, with a market share of 31.66%, reaching a market value of USD 2.02 billion by 2030.

  • Procter & Gamble (US), 3M (US), Johnson & Johnson (US), Clorox Company (US), Diamond Wipes International Inc. (US), Kimberly-Clark Corporation (US), Costco Wholesale Corporation (US), Pfizer Inc. (US), Reckitt Benckiser Group plc. (UK), Blistex Inc. (US), and others are the key market players.

Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Contact us and avail customized purchase options to meet your research needs. Get your queries resolved from an industry expert. Enquire before Buy

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.